首頁 › 子宮內膜癌 › 猶他州 › West Valley City
West Valley City, UT 的 子宮內膜癌 臨床試驗
10 項針對 子宮內膜癌 的研究正在 West Valley City(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
招募中1/2 期
- START Center for Cancer Research, West Valley City
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
招募中1 期
- START Mountain Region, LLC, West Valley City
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
招募中1/2 期
- START Mountain Region, West Valley City
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
招募中1 期
- START Mountain Region, West Valley City
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- START Mountain Region, West Valley City
A Study of LY4175408 in Participants With Advanced Cancer
招募中1 期
- START Mountain Region, West Valley City
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
招募中1 期
- START Mountain Region, LLC, West Valley City
其他城市的 子宮內膜癌 試驗
- Houston, TX68 項研究
- New York City, NY52 項研究
- Boston, MA50 項研究
- Arlington, VA39 項研究
- Nashville, TN38 項研究
- Los Angeles, CA34 項研究
- St. Louis, MO29 項研究
- Philadelphia, PA28 項研究
- San Antonio, TX27 項研究
- Columbus, OH25 項研究
- Chicago, IL25 項研究
- Oklahoma City, OK25 項研究
West Valley City 的其他研究
- 非小細胞肺癌25 項研究
- 大腸直腸癌17 項研究
- 乳癌13 項研究
- 三陰性乳癌13 項研究
- 轉移性癌症13 項研究
- 胰臟癌12 項研究
- 癌症(所有類型)11 項研究
- 卵巢癌11 項研究
- 頭頸部鱗狀細胞癌11 項研究
- 胃癌8 項研究
- 食道鱗狀細胞癌7 項研究
- 小細胞肺癌7 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。